Current Treatment Landscape for Second and Subsequent Lines of Therapy in Metastatic Urothelial Carcinoma

Download this slideset to review the latest data on treatment for patients with progressive urothelial carcinoma along with insights on new horizons for immunotherapy in urothelial carcinoma.
Alain Ravaud, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.76 MB
Released: September 21, 2020

Acknowledgements

Supported by an educational grant from
Pfizer, Inc. and EMD Serono

Related Content

Commentary from Nelson F. Sanchez, MD, on caring for transgender individuals, from the healthcare disparities they face to how healthcare professionals can improve their care, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD Released: June 28, 2022

Downloadable slideset from Eric Jonasch, MD on managing treatment-related adverse events for patients with RCC, from Clinical Care Options (CCO).

Eric Jonasch, MD Released: June 5, 2022

Downloadable slideset from Katy E. Beckermann, MD, PhD on the selection and sequencing of therapy for patients with advanced RCC after progression on first-line therapy, from Clinical Care Options (CCO).

Katy E. Beckermann, MD, PhD Released: June 5, 2022

Downloadable slideset from Naomi B. Haas, MD on adjuvant approaches and first line treatment options for patients with RCC, from Clinical Care Options (CCO).

person default Naomi B. Haas, MD Released: June 5, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings